Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip C. Sharpe

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|July 27, 2006
Transition metal complexes as mediator-titrants in protein redox potentiometryPaul V Bernhardt, Kuan-I Chen, Philip C Sharpe
Inorganic Chemistry|May 21, 1997
Structural and Electron Self-Exchange Rate Variations in Isomeric (Hexaamine)cobalt(III/II) ComplexesPaul V. Bernhardt, Lathe A. Jones, Philip C. Sharpe
Dalton Transactions (Cambridge, England : 2003)|September 26, 2007
Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activityPaul V Bernhardt, Piao Chin, Philip C Sharpe, et al.
Current Topics in Medicinal Chemistry|December 30, 2010
Synthetic and natural products as iron chelatorsPhilip C Sharpe, Des R Richardson, Danuta S Kalinowski, et al.
Journal of Medicinal Chemistry|October 30, 2007
Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analoguesDanuta S Kalinowski, Philip C Sharpe, Paul V Bernhardt, et al.
Journal of Medicinal Chemistry|July 6, 2010
Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activityPatric J Jansson, Philip C Sharpe, Paul V Bernhardt, et al.
Journal of Medicinal Chemistry|December 28, 2007
Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone seriesDanuta S Kalinowski, Philip C Sharpe, Paul V Bernhardt, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|September 30, 2005
Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activityPaul V Bernhardt, Piao Chin, Philip C Sharpe, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|September 28, 2007
Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligandsPaul V Bernhardt, Gregory J Wilson, Philip C Sharpe, et al.
Journal of Medicinal Chemistry|December 19, 2008
Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activityPaul V Bernhardt, Philip C Sharpe, Mohammad Islam, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|July 27, 2006
Transition metal complexes as mediator-titrants in protein redox potentiometryPaul V Bernhardt, Kuan-I Chen, Philip C Sharpe
Inorganic Chemistry|May 21, 1997
Structural and Electron Self-Exchange Rate Variations in Isomeric (Hexaamine)cobalt(III/II) ComplexesPaul V. Bernhardt, Lathe A. Jones, Philip C. Sharpe
Dalton Transactions (Cambridge, England : 2003)|September 26, 2007
Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activityPaul V Bernhardt, Piao Chin, Philip C Sharpe, et al.
Current Topics in Medicinal Chemistry|December 30, 2010
Synthetic and natural products as iron chelatorsPhilip C Sharpe, Des R Richardson, Danuta S Kalinowski, et al.
Journal of Medicinal Chemistry|October 30, 2007
Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analoguesDanuta S Kalinowski, Philip C Sharpe, Paul V Bernhardt, et al.
Journal of Medicinal Chemistry|July 6, 2010
Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activityPatric J Jansson, Philip C Sharpe, Paul V Bernhardt, et al.
Journal of Medicinal Chemistry|December 28, 2007
Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone seriesDanuta S Kalinowski, Philip C Sharpe, Paul V Bernhardt, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|September 30, 2005
Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activityPaul V Bernhardt, Piao Chin, Philip C Sharpe, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|September 28, 2007
Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligandsPaul V Bernhardt, Gregory J Wilson, Philip C Sharpe, et al.
Journal of Medicinal Chemistry|December 19, 2008
Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activityPaul V Bernhardt, Philip C Sharpe, Mohammad Islam, et al.
Pageof 2